Tuberculin skin test (TST) conversions rates, its relationship with interferon gamma release assay and safety and efficacy of 4 months rifampicin therapy (4R) for latent TB infection (LTBI) among nursing students in south India

P. James, D. J. Christopher, M. Pai, R. Gupta (Vellore, India; Montreal, Canada)

Source: Annual Congress 2010 - Special treatment options in tuberculosis
Session: Special treatment options in tuberculosis
Session type: Thematic Poster Session
Number: 3125
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. James, D. J. Christopher, M. Pai, R. Gupta (Vellore, India; Montreal, Canada). Tuberculin skin test (TST) conversions rates, its relationship with interferon gamma release assay and safety and efficacy of 4 months rifampicin therapy (4R) for latent TB infection (LTBI) among nursing students in south India. Eur Respir J 2010; 36: Suppl. 54, 3125

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The value of tuberculin skin test (TST) and interferon – gamma release assay (IGRA) in the diagnosis of latent tuberculosis infection (LTBI) according to age group
Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis
Year: 2010


Interferon-γ release assays (IGRA) vs. tuberculin skin testing (TST) for detecting latent tuberculosis infection (LTBI) in chronic hemodialysis (CH) patients
Source: Annual Congress 2008 - New tools in tuberculosis diagnosis
Year: 2008



High completion rates with directly observed preventive treatment (DOPT) of latent tuberculosis infection (LTBI) in Ethiopian immigrants (EI) to Israel
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I
Year: 2012

Comparison of tuberculin skin test (TST) and QuantiFERON-TB-Gold in Tube (QFT) in the diagnosis of latent tuberculosis infection (LTBI) in a prospective community study of contacts of tuberculosis (TB)
Source: Annual Congress 2010 - What is new in the diagnosis of tuberculosis?
Year: 2010


Prospective study of concordance between tuberculin skin test (TST) and interferon-γ (IFNγ) assay in asymptomatic paediatric tuberculosis (TB) contacts
Source: Annual Congress 2009 - Diagnostic tools in paediatric respiratory infection
Year: 2009

A retrospective study of the indications for the use of interferon gamma release assays (IGRA) in a United Kingdom (UK) district general hospital (DGH) tuberculosis (TB) clinic
Source: International Congress 2015 – Screening strategies in TB
Year: 2015


Comparison of a T-cell-based assay with tuberculin skin testing (TST) for diagnosis of latent tuberculosis infection (LTBI) in contact-tracing procedures
Source: Annual Congress 2005 - Diagnosis of tuberculosis and LTBI
Year: 2005


Latent tuberculosis infection (LTBI) detected by whole blood interferon gamma based assay among health care workers (HCW) in Poland
Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care
Year: 2007


A comparison of on-site versus remote physician follow up of directly observed preventive treatment (DOPT) for latent tuberculosis infection (LTBI) on completion rates
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II
Year: 2012

Interferon-gamma release assays (IGRA) for latent tuberculosis infection (LTBI) in children
Source: Annual Congress 2011 - Tuberculosis in pregnancy and childhood
Year: 2011


QuantiFERON-TB GIT (QFT-GIT) vs TST in diagnosis of latent tuberculosis (TB) infection (LTBI) in household TB contacts in poland
Source: Annual Congress 2009 - Tuberculosis contact screening
Year: 2009


Implementing an IGRA (interferon-gamma release assay) based TB screening pathway prior to starting biological treatments – Experience from a UK university hospital
Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis
Year: 2016

The changing indications for IGRA testing and impact on TB services in a UK district general hospital
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013


A prospective longitudinal study evaluating a T-cell-based assay for latent tuberculosis infection in healthcare workers in a general hospital in Beijing
Source: Annual Congress 2013 –Tuberculosis diagnosis
Year: 2013


Interferon-γ release assay (IGRA) in BCG vaccinated Greek army recruits reveals that most positive tuberculin skin tests (TST) are due to BCG and not to latent tb infection
Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease
Year: 2008

Tuberculin skin testing to the IGRA positive contacts of infectious tuberculosis cases for the treatment of latent tuberculosis infection
Source: International Congress 2015 – Latent TB infection and screening
Year: 2015


Contribution of the T-SPOT.TB assay for differentiating active versus latent tuberculosis infection (LTBI)
Source: Annual Congress 2006 - New methods to diagnose tuberculosis infection
Year: 2006


QFT-GIT vs TST in diagnosis of latent tuberculosis infection (LTBI) in Poland
Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Year: 2011


Cut-off point for tuberculin skin test (TST) and QuantiFERON (QTF) in the diagnosis of tuberculosis infection (TI) in a study of contacts of tuberculosis (TB)
Source: Annual Congress 2012 - Tuberculosis and immunologic assays
Year: 2012


Use of an IGRA test for prescribing latent TB infection therapy in 374 immigrants applying to night shelters in Milan, Italy
Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Year: 2011